Immediate release niacin effect at stratified lipid levels
نویسندگان
چکیده
منابع مشابه
Hypophosphatemic effect of niacin extended release in ischemic kidney disease
Ischemic nephropathy is an emerging cause of end stage renal disease, associated with many co-morbidities especially cardiovascular disease risk and derangement in calcium-phosphorus homeostasis resulting in hyperphosphatemia, influencing bones, a characteristic of advancing chronic kidney disease. The management of elevated serum phosphorus has been a challenge in this patient population with ...
متن کاملExtended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control
BACKGROUND The degree of glycemic control in patients with type 2 diabetes mellitus (T2DM) may alter lipid levels and may alter the efficacy of lipid-modifying agents. OBJECTIVE Evaluate the lipid-modifying efficacy of extended-release niacin/laropiprant (ERN/LRPT) in subgroups of patients with T2DM with better or poorer glycemic control. METHODS Post hoc analysis of clinical trial data fro...
متن کاملNiacin Ameliorates Lipid Disturbances due to Glucocorticoid Administration in Rats
Objective(s) This study was conducted to evaluate the effects of niacin on glucocorticoid-induced dyslipidemia and fatty liver in rats. Materials and Methods Twenty four adult male rats were divided randomly into four equal groups: 1- normal saline (control), 2- dexamathasone 0.125 mg/kg/day, i.m., 3- dexamathasone + niacin 200 mg/kg/day, oral gavages, 4- niacin. After 2 weeks, serum total c...
متن کاملLipid Control: Niacin, Bile Acid Sequestrants, Fibrates
From the name itself, lipoproteins are made up of complexes of lipids and proteins that primarily work as the transport system for cholesterol, triglycerides and other significant lipids needed by the body. Previously, the study of conditions related to problems in the metabolism of lipoproteins has been exclusive only for researchers focusing on lipids. However, it has been integrated into the...
متن کاملManagement of complex lipid abnormalities with a fixed dose combination of simvastatin and extended release niacin
ER niacin combined with simvastatin provides an additional option for achieving LDL-C and non-HDL-C goals for cardiovascular prevention, with greater efficacy in those with triglyceride levels >200 mg/dL. ER niacin 1000 mg combined with simvastatin 20 mg reduced LDL-C by 6%, non-HDL-C by 7%, and triglycerides by 13%, and raised HDL-C by 11% compared to simvastatin 20 mg alone. The 2000 mg dose ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: IJC Metabolic & Endocrine
سال: 2015
ISSN: 2214-7624
DOI: 10.1016/j.ijcme.2015.10.004